OS and PFS stratified by treatment options in early-stage patients receiving non–ANT-based or ANT-based regimens. OS (A) and PFS (B) of CMT vs CT alone in early-stage patients receiving non–ANT-based regimens before PSM. OS (C) and PFS (D) of CMT vs CT alone in early-stage patients receiving ANT-based regimens before PSM.